Literature DB >> 33207356

Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.

Yupeng Li1, Yu Shang2, Yi Yang1, Menghan Wang1, Dongping Yu1, Dongju Su1, Lei Liu3, Qin Wang4, Xiaona Zhang5, Juan Ren1, Hong Chen6.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a global emerging infectious disease.
OBJECTIVES: To analyze the initial clinical characteristics of COVID-19 suspected and confirmed patients on admission in order to find out which kinds may be more likely to get positive nucleic acid testing results, and to explore the risk factors associated with all-cause death.
METHODS: Medical records from 309 highly suspected cases with pneumonia were collected from February 13, 2020, to March 14, 2020, in a COVID-19-designated hospital of Wuhan. The majority of the clinical data were collected on the first day of hospital admission.
RESULTS: Of 309 patients with median age 64 years (interquartile ranges [IQR], 53-72 years), 111 patients (35.9%) were confirmed by nucleic acid testing (median age 64 years, IQR: 56-71 years; 48 males). Of those 111 patients, 13 (11.7%) patients died. In multivariate analysis, factors associated with positive testing included fatigue (odds ratios [OR] = 3.14; 95% confidence interval [CI]: 1.88-5.24, p < 0.001), cough (OR = 0.55; 95% CI: 0.32-0.95, p = 0.032), no less than 1 comorbidity (OR = 1.77; 95% CI: 1.06-2.98, p = 0.030), and severe pneumonia (OR = 2.67; 95% CI: 1.20-5.97, p = 0.016). Furthermore, age, dyspnea, noneffective antibiotic treatment, white blood cell, lymphocyte, platelets, and organ dysfunction (e.g., higher lactate dehydrogenase) were significantly associated with all-cause in-hospital death in patients with COVID-19.
CONCLUSION: Patients with severe forms of this disease were more likely to get positive results. Age and organ dysfunction were associated with a greater risk of death.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Coronavirus disease 2019; Negative SARS-CoV-2 testing; Pneumonia; Positive SARS-CoV-2 testing; Risk factors

Mesh:

Substances:

Year:  2020        PMID: 33207356     DOI: 10.1159/000508398

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

Review 1.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Authors:  Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Anouk Tans; Stéphanie Janssens; Dakshitha Wickramasinghe; Viktor Lannoy; Sebastiaan R A Horn; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2022-05-20

2.  Changes in Serum Liver Function for Patients with COVID-19: A 1-Year Follow-Up Study.

Authors:  Xiaoli Zhu; Jing Wang; Juping Du; Shuaishuai Chen; Shiyong Chen; Jun Li; Bo Shen
Journal:  Infect Drug Resist       Date:  2022-04-15       Impact factor: 4.177

3.  Predictive Score of Risk Associated with Progression of Patients with COVID-19 Pneumonia in Wuhan, China: the ALA Score.

Authors:  Menghan Wang; Dongping Yu; Yu Shang; Xiaona Zhang; Yi Yang; Shuai Zhao; Dongju Su; Lei Liu; Qin Wang; Juan Ren; Yupeng Li; Hong Chen
Journal:  Arab J Sci Eng       Date:  2021-06-28       Impact factor: 2.334

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.